Status:
COMPLETED
Use of Varenicline for 4-weeks Prior to Quitting
Lead Sponsor:
Queen Mary University of London
Conditions:
Tobacco Dependence
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Varenicline (Champix) is a relatively new medicine that is effective in helping people to quit smoking. It is normally started 1-week before stopping smoking and used for up to 12-24 weeks. We are try...
Eligibility Criteria
Inclusion
- Smokers seeking treatment
- Aged 18 and over
- Consenting to take part in the trial
Exclusion
- Pregnant or breastfeeding
- End-stage renal disease
- Used varenicline in the past 6 months
- Unable to fill in questionnaires in English
- Current psychiatric illness
- Current serious illness including uncontrolled hypertension and recent cardiac event
- Sensitivity to varenicline currently enrolled in other research projects.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT00789074
Start Date
July 1 2009
End Date
March 1 2010
Last Update
December 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tobacco Dependence Research and Treatment Unit
London, United Kingdom, E1 2JH